3rd week on tirzepatide 3 update of taking (GLP-1) for my chronic pain & chronic inflammation with suspicions of diaphragmatic endometriosis (already diagnosed with Lyme disease, thoracic outlet syndrome & I've been on Tirzepatide (GLP2)

Results: Early GLP-1 RA use demonstrated a modest but significant association with reduced overall cancer risk (HR 0.93

Anti-inflammatory and Antifibrotic Effects Chronic inflammation and myocardial fibrosis are hallmarks of HF progression

Until more is known, decisions must be careful and thoughtful

There have been a few early studies that look at combining both a GLP-1 medication, like semaglutide, with a drug that prevents muscle mass atrophy or loss

This treatment helps eliminate toxins, heavy metals, and free radicals, promoting cellular health and overall vitality

The Rebound Effect One of the most widely reported outcomes of discontinuing GLP-1 and GIP receptor agonists like tirzepatide is significant weight regain